Companies with a Future performance score of at least 3, ordered by Future performance score.
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin.
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibodies, and specializes in antibody drug conjugates in Germany.
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide.
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide.
Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide.
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally.